BioScan touch i8 an important tool in the assessment and targeting of Malnutrition
During ageing and in acute setting many factors contribute to the risk of malnutrition. It is essential for better outcomes we understand the causes in order to formulate appropriate treatment strategies. Malnutrition is associated with both over- and under- nutrition. It is also common in hospital patients. Nutritional depletion is associated with worse patient outcome.
- Malnutrition
- Fat Mass
- Muscle Mass
- Lean Mass
- Body Cell Mass (BCM)
- Cellular Biomarker (Phase Angle)
- Over Hydration (OH) (Excess Fluid)
- Dehydration
- Total Body Water
- Extracellular Water
- Intracellular Water
- Fat Free Mass Hydration
Helping to Minimise & Prevent Medical Complications
Proper assessment of nutritional status in hospital patients can help to minimise or prevent complications, readmissions and mortality rates. In clinical patients with oedema the assessment of Malnutrition is difficult as oedema can be a confounding factor.
Increase in weight due to the accumulation of fluids will not be representative of the true individual status. Patients with oedema are considered severely malnourished, regardless of their weight-for-height. Consequently, assessment and treating malnutrition is important and can lead to improved patient outcome.
- Malnutrition and its contribution to mortality
- Malnutrition and infectious diseases
- Emergency rehabilitation
- Acute malnutrition associated with high mortality rates
- Malnourished due to infectious disease – Malaria, Diarrhoea, Measles, ARLI, HIV/AIDS
Malnutrition if untreated or undiagnosed can lead to negative outcomes
- Higher morbidity and mortality rates
- Loss of lean body mass (sarcopenia)
- Delayed wound healing
- Impaired immunity
- Longer hospital stays and higher readmission rate
- Reduced quality of life and increased costs for the hospital
Assessment with BioScan touch i8 can lead to early intervention and diagnoses help improve patient care
- Reduced mortality rates
- Improved wound healing
- Improved immune function
- Decreased susceptibility to infection
- Reduce complications such as pressure ulcers and infections
- Shortened hospital stays
- Lower costs of care
- Improve quality of life
Request a copy of our Brochure
Get in touch
Maltron International Ltd
20 Sirdar Road, Rayleigh,
Essex, SS6 7XF
Tel: +44 (0)1268 778251
Fax: +44 (0)1268 745176
Email: info@maltronint.com
The new BioScan touch i8
Smart technology that understands your
language, learns from your experience and helps provide better patient outcome.
The Body Composition Monitor of tomorrow defining new standards.
